Pierre‐Éric Juif

668 total citations
28 papers, 517 citations indexed

About

Pierre‐Éric Juif is a scholar working on Molecular Biology, Physiology and Behavioral Neuroscience. According to data from OpenAlex, Pierre‐Éric Juif has authored 28 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Physiology and 5 papers in Behavioral Neuroscience. Recurrent topics in Pierre‐Éric Juif's work include Sphingolipid Metabolism and Signaling (11 papers), Stress Responses and Cortisol (5 papers) and Pain Mechanisms and Treatments (5 papers). Pierre‐Éric Juif is often cited by papers focused on Sphingolipid Metabolism and Signaling (11 papers), Stress Responses and Cortisol (5 papers) and Pain Mechanisms and Treatments (5 papers). Pierre‐Éric Juif collaborates with scholars based in Switzerland, France and United Kingdom. Pierre‐Éric Juif's co-authors include Jasper Dingemanse, Pierrick Poisbeau, Mike Ufer, Yannick Goumon, Ulrike Hanesch, Fernand Anton, Clemens Muehlan, Jules A. A. C. Heuberger, Joop van Gerven and Alexandre Charlet and has published in prestigious journals such as Journal of Neuroscience, Pain and International Journal of Molecular Sciences.

In The Last Decade

Pierre‐Éric Juif

27 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pierre‐Éric Juif Switzerland	15	150	115	104	82	63	28	517
Shuwei Jia China	12	92 0.6×	189 1.6×	108 1.0×	51 0.6×	69 1.1×	31	489
T Nogimori Japan	15	171 1.1×	70 0.6×	174 1.7×	70 0.9×	177 2.8×	89	760
Aurélie Caillon Switzerland	10	169 1.1×	311 2.7×	262 2.5×	164 2.0×	42 0.7×	16	675
Alfredo Bellon United States	15	257 1.7×	17 0.1×	55 0.5×	39 0.5×	97 1.5×	32	569
Silke Kreitz Germany	9	65 0.4×	39 0.3×	32 0.3×	146 1.8×	85 1.3×	20	515
Katja Tenner Germany	6	144 1.0×	82 0.7×	59 0.6×	30 0.4×	158 2.5×	6	418
Alison Berent‐Spillson United States	13	83 0.6×	44 0.4×	17 0.2×	115 1.4×	92 1.5×	15	509
Richard Bayles Australia	12	121 0.8×	38 0.3×	18 0.2×	72 0.9×	94 1.5×	18	520
Michael Whiteside United States	7	95 0.6×	39 0.3×	77 0.7×	79 1.0×	86 1.4×	8	674
Kate Beecher Australia	12	82 0.5×	29 0.3×	38 0.4×	82 1.0×	81 1.3×	27	462

Countries citing papers authored by Pierre‐Éric Juif

Since Specialization

Citations

This map shows the geographic impact of Pierre‐Éric Juif's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre‐Éric Juif with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre‐Éric Juif more than expected).

Fields of papers citing papers by Pierre‐Éric Juif

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre‐Éric Juif. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre‐Éric Juif. The network helps show where Pierre‐Éric Juif may publish in the future.

Co-authorship network of co-authors of Pierre‐Éric Juif

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre‐Éric Juif. A scholar is included among the top collaborators of Pierre‐Éric Juif based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre‐Éric Juif. Pierre‐Éric Juif is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bauer, Todd M., Armando Santoro, Chia‐Chi Lin, et al.. (2023). Phase I/Ib, open-label, multicenter, dose-escalation study of the anti-TGF-β monoclonal antibody, NIS793, in combination with spartalizumab in adult patients with advanced tumors. Journal for ImmunoTherapy of Cancer. 11(11). e007353–e007353. 24 indexed citations

Juif, Pierre‐Éric, et al.. (2022). Lack of Effect of Cenerimod, a Selective S1P1 Receptor Modulator, on the Pharmacokinetics of a Combined Oral Contraceptive. International Journal of Molecular Sciences. 23(23). 14986–14986.

Juif, Pierre‐Éric, et al.. (2021). PK/PD modeling of a clazosentan thorough QT study with hysteresis in concentration-QT and RR-QT. Journal of Pharmacokinetics and Pharmacodynamics. 48(2). 213–224. 5 indexed citations

Juif, Pierre‐Éric, Jasper Dingemanse, & Mike Ufer. (2021). Clinical Pharmacology of Clazosentan, a Selective Endothelin A Receptor Antagonist for the Prevention and Treatment of aSAH-Related Cerebral Vasospasm. Frontiers in Pharmacology. 11. 628956–628956. 16 indexed citations

Dingemanse, Jasper, et al.. (2021). Insights from In Vitro and Clinical Data to Guide Transition from the Novel P2Y12 Antagonist Selatogrel to Clopidogrel, Prasugrel, and Ticagrelor. Thrombosis and Haemostasis. 121(6). 755–766. 9 indexed citations

Juif, Pierre‐Éric, et al.. (2020). Association Between Vomiting and QT Hysteresis: Data from a TQT Study with the Endothelin A Receptor Antagonist Clazosentan. The AAPS Journal. 22(5). 103–103. 4 indexed citations

Juif, Pierre‐Éric, et al.. (2019). Modelling pharmacokinetics and pharmacodynamics of the selective S1P₁ receptor modulator cenerimod in healthy subjects and systemic lupus erythematosus patients. British Journal of Clinical Pharmacology. 86(4). 791–800. 4 indexed citations

Juif, Pierre‐Éric, et al.. (2018). Clinical Pharmacology of the Reversible and Potent P2Y₁₂ Receptor Antagonist ACT‐246475 After Single Subcutaneous Administration in Healthy Male Subjects. The Journal of Clinical Pharmacology. 59(1). 123–130. 30 indexed citations

Muehlan, Clemens, et al.. (2018). Accelerated Development of the Dual Orexin Receptor Antagonist ACT‐541468: Integration of a Microtracer in a First‐in‐Human Study. Clinical Pharmacology & Therapeutics. 104(5). 1022–1029. 57 indexed citations

10.

Juif, Pierre‐Éric, Daniela Baldoni, Darren Wilbraham, et al.. (2017). Pharmacokinetics, Pharmacodynamics, Tolerability, and Food Effect of Cenerimod, a Selective S1P1 Receptor Modulator in Healthy Subjects. International Journal of Molecular Sciences. 18(12). 2636–2636. 12 indexed citations

11.

Juif, Pierre‐Éric, et al.. (2017). A pharmacokinetic drug–drug interaction study between selexipag and midazolam, a CYP3A4 substrate, in healthy male subjects. European Journal of Clinical Pharmacology. 73(9). 1121–1128. 16 indexed citations

12.

Jurčević, Stipo, et al.. (2016). Effects of multiple-dose ponesimod, a selective S1P<sub>1</sub> receptor modulator, on lymphocyte subsets in healthy humans. Drug Design Development and Therapy. Volume11. 123–131. 15 indexed citations

13.

Juif, Pierre‐Éric, et al.. (2016). Absolute Bioavailability of Ponesimod, a Selective S1P1 Receptor Modulator, in Healthy Male Subjects. European Journal of Drug Metabolism and Pharmacokinetics. 42(1). 129–134. 8 indexed citations

14.

Juif, Pierre‐Éric, Matthias Hoch, Daniele D’Ambrosio, & Jasper Dingemanse. (2015). Biocomparison of Three Formulations of the S1P1 Receptor Modulator Ponesimod in Healthy Subjects. Drugs in R&D. 15(2). 203–210. 8 indexed citations

15.

Juif, Pierre‐Éric, Meggane Melchior, & Pierrick Poisbeau. (2014). Characterization of the fast GABAergic inhibitory action of etifoxine during spinal nociceptive processing in male rats. Neuropharmacology. 91. 117–122. 8 indexed citations

16.

Zell, Vivien, Pierre‐Éric Juif, Ulrike Hanesch, et al.. (2014). Corticosterone analgesia is mediated by the spinal production of neuroactive metabolites that enhance GABAergic inhibitory transmission on dorsal horn rat neurons. European Journal of Neuroscience. 41(3). 390–397. 17 indexed citations

17.

Zell, Vivien, Pierre‐Éric Juif, Adrien Lacaud, et al.. (2013). Etifoxine analgesia in experimental monoarthritis: A combined action that protects spinal inhibition and limits central inflammatory processes. Pain. 155(2). 403–412. 18 indexed citations

18.

Juif, Pierre‐Éric & Pierrick Poisbeau. (2013). Neurohormonal effects of oxytocin and vasopressin receptor agonists on spinal pain processing in male rats. Pain. 154(8). 1449–1456. 77 indexed citations

19.

Juif, Pierre‐Éric, Jean‐Didier Breton, Mathieu Rajalu, et al.. (2013). Long-Lasting Spinal Oxytocin Analgesia Is Ensured by the Stimulation of Allopregnanolone Synthesis Which Potentiates GABA_AReceptor-Mediated Synaptic Inhibition. Journal of Neuroscience. 33(42). 16617–16626. 41 indexed citations

20.

Juif, Pierre‐Éric, Fernand Anton, & Ulrike Hanesch. (2011). Pain behavior and spinal cell activation due to carrageenan-induced inflammation in two inbred rat strains with differential hypothalamic–pituitary–adrenal axis reactivity. Physiology & Behavior. 105(4). 901–908. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact